Trump ad­min­is­tra­tion dou­bles down on slash­ing the bud­get at NIH, FDA — with a user fee hike for bio­phar­ma

Pres­i­dent Don­ald Trump is stick­ing with a con­tro­ver­sial plan to try and carve bil­lions out of the bud­gets for the NIH and the FDA, look­ing to slash re­search spend­ing and force bio­phar­ma com­pa­nies to cough up more cash for drug re­views.

But his pro­pos­als are al­ready deep in hot wa­ter — and that’s be­fore you start count­ing De­mo­c­ra­t­ic votes. A num­ber of Re­pub­li­can law­mak­ers have reg­is­tered their op­po­si­tion to these kinds of cuts to the NIH and FDA, in­clud­ing some of the par­ty’s most pow­er­ful fig­ures.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.